Ischaemic heart disease (e.g. coronary artery disease) is responsible for almost half of all cardiovascular deaths with around 30% of all deaths worldwide in cardiovascular diseases.
LIFE is a multicentre, open-label, prospective, observational study estimating health related QoL and functional endpoints with initiation of Ivabradine in older patients.
Increased heart rate (HR) is an independent risk factor for cardiovascular outcomes in chronic heart failure (HF).
Heart failure (HF) constitutes a major public health problem. It has a substantial clinical, social, and economic burden, notably due to significant functional limitations and the reduced quality of life of patients.
The Cardiovascular Health Study estimated CHF incidence as 19.3 per 1000 person-years in those aged >65 years.
Chronic heart failure (CHF) is a clinical syndrome frequently accompanied by a high load of co-morbidities and characterized by poor outcomes, despite the provision of optimal medical guideline-directed treatments.